News

Filter

Current filters:

IpsenFinancial

1 to 9 of 37 results

This week’s third quarter pharma financial results in brief

This week’s third quarter pharma financial results in brief

31-10-2014

Several pharma, biotech and generics makers announced their third quarter results this week. Here are…

AmgenBayerDr Reddy's LaboratoriesFinancialGilead SciencesIpsenMerck & CoNicOxNovartisNovo NordiskPfizerRecordatiSanofiShireTeva

Specialty care and Somatuline drive Ipsen's positive third quarter financials

Specialty care and Somatuline drive Ipsen's positive third quarter financials

29-10-2014

French drugmaker Ipsen has reported sales of 329 million euros ($419.1 million) for the third quarter…

DysportFinancialFranceIpsenPharmaceuticalSomatuline

Ipsen posts strong earnings growth for first-half 2014

Ipsen posts strong earnings growth for first-half 2014

29-08-2014

French drugmaker Ipsen has reported first half 2014 sales of 638.7 million euros ($845.1 million), up…

FinancialIpsenPharmaceutical

Ipsen sales up in first quarter, boosted by specialty care

Ipsen sales up in first quarter, boosted by specialty care

30-04-2014

French drugmaker Ipsen has reported sales of 305.9 million euros ($423 million) for the first quarter…

Business FinanceBusiness FinanceDecapeptylDysportEURFinancialFranceIpsenPfizerPharmaceuticalSomatulineTriptorelin

Ipsen returns to profit, with drug sales up 2.1%

28-02-2014

Full-year 2013 group revenues at French drugmaker Ipsen came in at 1.28 billion euros ($17.59 billion),…

FinancialIpsenPharmaceutical

Ipsen’s sales grow 2.2% in 2013, but miss expectations

Ipsen’s sales grow 2.2% in 2013, but miss expectations

28-01-2014

French drugmaker Ipsen posted solid sales growth for fourth-quarter and full-year 2013, though there…

FinancialIpsenPharmaceutical

Ipsen, a good European mid-cap to watch, says US analyst

Ipsen, a good European mid-cap to watch, says US analyst

27-01-2014

Most American investors are familiar with large European drugmakers like Sanofi and Novartis but the…

FinancialIpsenOncologyPharmaceuticalResearchSomatulinetasquinimod

Mixed geographical performance from Ipsen

30-10-2013

French drugmaker Ipsen today reported sales for the third quarter of 2013, noting a significant slowdown…

FinancialIpsenPharmaceutical

1 to 9 of 37 results

Back to top